Moreover, exogenous administration of IL-33 to WT 4T1 tumor-bearing mice decreased NK cell activation and cytotoxicity and promoted tumor progression (71), thus suggesting a detrimental role for IL-33 in NK cell-dependent anti-tumor responses. Here, IL33 is linked to neoplasm.